In summary, we have uncovered the USP10-SKP2-Bcr-Abl axis in the genesis and progression of CML, which provides novel insight into the dysregulation of cell cycle control. Here, SKP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.